Ahamad R, Bhandari U, Nabi S, Sharma S
Iran J Basic Med Sci. 2024; 27(11):1447-1455.
PMID: 39386240
PMC: 11459336.
DOI: 10.22038/ijbms.2024.78221.16908.
Loeb G, Kathail P, Shuai R, Chung R, Grona R, Peddada S
Nat Genet. 2024; 56(10):2078-2092.
PMID: 39256582
DOI: 10.1038/s41588-024-01904-6.
Ligocki A, Vinson A, Yachnis A, Dunn Jr W, Smith D, Scott E
Sci Adv. 2024; 10(36):eadn3259.
PMID: 39231237
PMC: 11373606.
DOI: 10.1126/sciadv.adn3259.
Loeb G, Kathail P, Shuai R, Chung R, Grona R, Peddada S
bioRxiv. 2024; .
PMID: 38948875
PMC: 11212968.
DOI: 10.1101/2024.06.18.599625.
Liu S, Li Y, Li Z, Wu S, Harrold J, Shah D
J Pharmacokinet Pharmacodyn. 2024; 51(5):449-476.
PMID: 38691205
DOI: 10.1007/s10928-024-09922-x.
Altered platelet-megakaryocyte endocytosis and trafficking of albumin and fibrinogen in RUNX1 haplodeficiency.
Del Carpio-Cano F, Mao G, Goldfinger L, Wurtzel J, Guan L, Afaque Alam M
Blood Adv. 2024; 8(7):1699-1714.
PMID: 38330198
PMC: 10997914.
DOI: 10.1182/bloodadvances.2023011098.
Revisiting PINI Scoring in Light of Recent Biological Advances.
Ingenbleek Y
Nutrients. 2023; 15(8).
PMID: 37111065
PMC: 10146499.
DOI: 10.3390/nu15081846.
Podocyturia: an earlier biomarker of cardiovascular outcomes.
Eid A, Habib R, Chehab O, Al Jalbout N, Tamim H, Makki M
Sci Rep. 2022; 12(1):21563.
PMID: 36513746
PMC: 9747803.
DOI: 10.1038/s41598-022-26162-6.
Prognostic value of the controlling nutritional status score in patients with myelodysplastic syndromes.
Chen Q, Chen K, Wang S, Zhang L, Shi Y, Tao S
Front Nutr. 2022; 9:902704.
PMID: 35967813
PMC: 9363897.
DOI: 10.3389/fnut.2022.902704.
TMBIM6 promotes diabetic tubular epithelial cell survival and albumin endocytosis by inhibiting the endoplasmic reticulum stress sensor, IRE1α.
Xie H, Shi Y, Zhou Y, Liu H
Mol Biol Rep. 2022; 49(10):9181-9194.
PMID: 35857174
DOI: 10.1007/s11033-022-07744-z.
Low Serum Albumin Is Associated with Poor Prognosis in Patients Receiving Peritoneal Dialysis Treatment.
Shi Y, Cai J, Shi C, Liu C, Zhou J, Li Z
J Healthc Eng. 2022; 2022:7660806.
PMID: 35480153
PMC: 9038379.
DOI: 10.1155/2022/7660806.
Defective Cystinosin, Aberrant Autophagy-Endolysosome Pathways, and Storage Disease: Towards Assembling the Puzzle.
Rega L, De Leo E, Nieri D, Luciani A
Cells. 2022; 11(3).
PMID: 35159136
PMC: 8834619.
DOI: 10.3390/cells11030326.
The recycling regulation of sodium-hydrogen exchanger isoform 3(NHE3) in epithelial cells.
Ran L, Yan T, Zhang Y, Niu Z, Kan Z, Song Z
Cell Cycle. 2021; 20(24):2565-2582.
PMID: 34822321
PMC: 8726692.
DOI: 10.1080/15384101.2021.2005274.
High Doses of Essential Oil of Induces Renal Tubular Damage.
Silva K, Peruchetti D, Sirtoli G, Takiya C, Pinheiro A, Leal-Cardoso J
Plants (Basel). 2021; 10(7).
PMID: 34371603
PMC: 8309426.
DOI: 10.3390/plants10071400.
Vascular permeability in chronic rhinosinusitis enhances accumulation and retention of nanoscale pegylated liposomes.
Khurana N, Yathavan B, Jedrzkiewicz J, Gill A, Pulsipher A, Alt J
Nanomedicine. 2021; 38:102453.
PMID: 34363985
PMC: 10499165.
DOI: 10.1016/j.nano.2021.102453.
Antiproteinuric and Hyperkalemic Mechanisms Activated by Dual Versus Single Blockade of the RAS in Renovascular Hypertensive Rats.
Correa J, Boaro K, Sene L, Polidoro J, Salles T, Martins F
Front Physiol. 2021; 12:656460.
PMID: 34177612
PMC: 8221266.
DOI: 10.3389/fphys.2021.656460.
Renal Handling of Albumin-From Early Findings to Current Concepts.
Gburek J, Konopska B, Golab K
Int J Mol Sci. 2021; 22(11).
PMID: 34071680
PMC: 8199105.
DOI: 10.3390/ijms22115809.
Electrochemical Detection of Morphine in Untreated Human Capillary Whole Blood.
Verrinder E, Wester N, Leppanen E, Lilius T, Kalso E, Mikladal B
ACS Omega. 2021; 6(17):11563-11569.
PMID: 34056312
PMC: 8154029.
DOI: 10.1021/acsomega.1c00773.
Oxidized Albumin as a Mediator of Kidney Disease.
Figueroa S, Araos P, Reyes J, Gravez B, Barrera-Chimal J, Amador C
Antioxidants (Basel). 2021; 10(3).
PMID: 33800425
PMC: 8000637.
DOI: 10.3390/antiox10030404.
LCRF-0006, a small molecule mimetic of the N-cadherin antagonist peptide ADH-1, synergistically increases multiple myeloma response to bortezomib.
Mrozik K, Cheong C, Hewett D, Noll J, Opperman K, Adwal A
FASEB Bioadv. 2020; 2(6):339-353.
PMID: 32617520
PMC: 7325588.
DOI: 10.1096/fba.2019-00073.